JPRN-UMIN000040764招募中未知
Evaluation of the effect of switching from LAMA / LABA therapy to ICS-containing triple therapy (ICS/LAMA/LABA) in patients with COPD. single center, real world study - The effect of switching from LAMA / LABA therapy to ICS / LAMA / LABA therapy in patients with COPD. single center, real world study
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School0 个研究点目标入组 100 人开始时间: 2020年6月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Excluded from the study were those with a documented history of asthma, a bronchodilator response (BDR) to 400 microgram salbutamol shown as a FEV1 change of and or more than 200 ml or peripheral eosinophilia more than 150, presence of typical asthma symptoms of atopy or history of IgE more than 170IU/ml and those confirmed to have received LAMA, LABA or ICS other than the study drug or their combination.
研究者
相似试验
已完成
不适用
Investigation of the effects of switching to a high genetic barrier protease inhibitor based regimen on low level viremia, immune activation and neurocognitive performance in patients on antiviral therapyaidsHIV1002146010047438NL-OMON44785niversitair Medisch Centrum Utrecht65
招募中
不适用
The efficacy and safety of switching from linagliptin to once-weekly dulaglutide in hemodialysis patients with type 2 diabetes mellitus (pilot study)Type 2 diabetes mellitusJPRN-UMIN000021944Minamisenju Hospital20
已完成
2 期
Is LMA applicable in cochlear implant?Condition 1: cochlear implant. Condition 2: Hearing Loss, Deafness.cochlear implant, Presence of otological and audiological implantsHearing Loss, DeafnessIRCT2013011512134N1Vice chancellor for research, Shahid Beheshti University of Medical Sciences , Loghman Hospital60
尚未招募
不适用
Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemia (Study on inpatients)type 2 diabetesJPRN-UMIN000012458The Third Department of Internal Medicine(Department of Diabetes, Endocrinology and Metabolism),Tokyo Medical University30
尚未招募
不适用
Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemiatype 2 diabetesJPRN-UMIN000012459The Third Department of Internal Medicine(Department of Diabetes, Endocrinology and Metabolism),Tokyo Medical University50
